Fexofenadine Hydrochloride And Pseudoephedrine Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 0536-1431

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Fexofenadine Hydrochloride And Pseudoephedrine Hydrochloride (NDC 0536-1431). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rugby Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fexofenadine-fig1 (Fexofenadine Fig1)

This is information about a medication called "Unvarnished Zone." The text includes details about the product's composition (Fexofenadine HCI and Pseudoephedrine HCI), dosages (60 mg/120 mg), and features (12 Hour, Non-Drowsy, Extended-Release Tablets). The medication is designed to provide indoor/outdoor relief for symptoms like nasal and sinus congestion, sneezing, runny nose, and itchy eyes/throat due to allergies or colds. It is stated that the product is part of Sancfirou Tables and is registered under the name Alegra-D® (NDC 0536-1431-34).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.